医学
心脏再同步化治疗
回顾性队列研究
病历
内科学
糖尿病
外科
植入式心律转复除颤器
心脏病学
射血分数
心力衰竭
内分泌学
作者
Banu Karaca,Fatma Esin,Emre Özdemir,Muhammet Mücahit Tiryaki,Selin Özdemir,Tuncay Kırış
出处
期刊:Angiology
[SAGE]
日期:2022-11-12
卷期号:75 (1): 15-21
标识
DOI:10.1177/00033197221139715
摘要
This study aimed to evaluate the utility of the systemic immune-inflammation index (SII) in predicting the development of Cardiac Implantable Electronic Device (CIED) infections. A retrospective analysis was performed using the medical records of 2185 patients who underwent CIED (including de novo, revision, or upgrade) implantation at our institution from January 2012 to December 2019. We recorded CIED infections and risk factors according to the patient, device, and procedural characteristics during the median 28.7 months (6.2–56.8) follow-up. CIED infections were identified in 52 patients. Diabetes, chronic renal disease, SII before implantation, new cardiac resynchronization therapy (CRT) implantation, CRT-battery replacement, revision or upgrade, and the number of previous procedures were independent predictors of CIED infections. The area under the curve (AUC) of SII to predict CIED infection was .733 (95% CI: .654-.811). A raised SII may be a useful predictor of CIED infection.
科研通智能强力驱动
Strongly Powered by AbleSci AI